Invesaro

Stocks Health care HCA

NYSE · Health care

HCA Healthcare, Inc. (HCA)

HCA Healthcare, Inc. brought in $76.4B of revenue over the twelve months to March 31, 2026, up 6.7% from a year earlier. Net income was $6.8B, a net margin of 8.9%. Operating cash flow minus capital spending left $7.7B of free cash flow in fiscal 2025. At March 31, 2026 it held $940M in cash against $44.4B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 28, 2026.

Free, no password. An email when HCA files with the SEC.

Price
$470.44
+2.10% on the day · October 14, 2026
52-week range $353.99 to $556.52
Market cap
$101.9B
Revenue (last 12 months)
$76.4B
+6.7% year on year
Net margin
8.9%
P/E
16.6
on FY2025 diluted EPS

Key facts about HCA Healthcare, Inc.

Net worth
HCA Healthcare, Inc. has a market value (market cap) of $101.9B at the latest share price, and shareholders' equity of -$6.3B on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $75.6B (+7.1% year on year), with net income of $6.8B. Over the 12 months to March 31, 2026: revenue $76.4B, net income $6.8B.
Cash flow
In fiscal 2025 operations brought in $12.6B of cash; after $4.9B of capital spending, free cash flow was $7.7B.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 28, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
HCA Healthcare, Inc.'s next report is expected around October 23, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
HCA Healthcare, Inc. declared dividends of $2.88 per share in fiscal 2025, a yield of 0.61% at the current price.

What HCA Healthcare, Inc. does

HCA Healthcare operates general acute care hospitals, freestanding surgery centers, emergency rooms, and diagnostic clinics. It provides inpatient medical and surgical treatments, outpatient procedures, and emergency care services directly to patients across regional healthcare markets. Its shares trade on NYSE under the ticker HCA.

Revenue and profit by year

Revenue
FY18: $46.7B $46.7B FY18FY19: $51.3B $51.3B FY19FY20: $51.5B $51.5B FY20FY21: $58.8B $58.8B FY21FY22: $60.2B $60.2B FY22FY23: $65B $65B FY23FY24: $70.6B $70.6B FY24FY25: $75.6B $75.6B FY25
Net income
FY18: $3.8B $3.8B FY18FY19: $3.5B $3.5B FY19FY20: $3.8B $3.8B FY20FY21: $7B $7B FY21FY22: $5.6B $5.6B FY22FY23: $5.2B $5.2B FY23FY24: $5.8B $5.8B FY24FY25: $6.8B $6.8B FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$75.6Bn/a$6.8B$28.33$7.7B
2024$70.6Bn/a$5.8B$22.00$5.6B
2023$65Bn/a$5.2B$18.97$4.7B
2022$60.2Bn/a$5.6B$19.15$4.1B
2021$58.8Bn/a$7B$21.16$5.4B
2020$51.5Bn/a$3.8B$10.93$6.4B

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around October 23, 2026.

Estimated from its filing rhythm: 52 weeks after its report of October 24, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where HCA ranks in Health care

Revenue$75.6B
#10 of 751 in Health care · Top 1%
Revenue growth+7.1%
#325 of 532 in Health care · Bottom 39%
Net margin9.0%
#120 of 544 in Health care · Top 22%
Free cash flow margin10.2%
#126 of 490 in Health care · Top 26%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

HCA Healthcare, Inc. declared $2.88 per share in fiscal 2025. At the current price that is a yield of 0.61%. It paid out $679M in cash dividends, 10% of its net income.

Fiscal yearPer sharePaid outOf profit
2025$2.88$679M10%
2024$2.64$690M12%
2023$2.40$661M13%
2022$2.24$653M12%
2021$1.92$624M9%
2020$0.43$153M4%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What HCA Healthcare, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. July 29, 2026
  2. July 28, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. July 24, 2026
  4. July 14, 2026
  5. June 18, 2026
  6. April 30, 2026
  7. April 30, 2026
  8. April 29, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 4.3% to $19.1B versus the same quarter last year; diluted EPS $7.15 versus $6.45.
  9. April 28, 2026
  10. April 27, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 11, 2026. Insider transactions on SEC

What is HCA worth? A DCF from its reported cash flow

Insider trades

What the people running HCA Healthcare, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 26, 2026 McAlevey Michael REVP & Chief Legal & Admin Off. Other changeindirect 7,769 $429.00 $3.3M Form 4
May 7, 2026 Marks Mike AEVP and CFO Gave as a gift 3,336 - - Form 4
May 7, 2026 Marks Mike AEVP and CFO Gave as a giftindirect 3,336 - - Form 4
April 28, 2026 Frist Thomas F IIIDirector, 10% owner Received as pay 1,041 - - Form 4
April 28, 2026 Frist William RDirector, 10% owner Received as pay 809 - - Form 4
April 28, 2026 Chidsey JohnDirector Received as pay 809 - - Form 4
April 28, 2026 Deparle Nancy AnnDirector Received as pay 509 - - Form 4
April 28, 2026 Johnston Hugh FDirector Received as pay 809 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HCA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Thomas F. Frist, Jr.13D, may seek influence with 5 related filers 31.6% 70,555,590 February 10, 2026
Vanguard Capital Management13G, passive 5.25% 11,746,315 April 30, 2026

Latest filings below 5%: The Vanguard Group 0% (March 27, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1,337 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.13,003,600$5.07B-359,666
Vanguard Capital Management LLC10,141,708$3.95B-36,654
Sanders Capital, LLC8,828,287$3.44B-128,858
State Street Corp7,469,035$2.91B-70,515
First Eagle Investment Management, LLC6,591,130$2.57B+3,336,560
Wellington Management Group Llp4,707,473$1.84B+799,761
Geode Capital Management, LLC3,668,008$1.42B-24,505
Vanguard Portfolio Management LLC2,712,828$1.06B-44,951
Morgan Stanley2,586,771$1.01B+291,891
Goldman Sachs Group Inc2,464,314$960.8M+328,242
Jpmorgan Chase & Co2,285,832$896.8M-176,143
Arrowstreet Capital, Limited Partnership2,209,485$861.5M+44,227
Norges Bank2,145,367$836.5Mnew
Capital World Investors1,977,121$770.9M+4,692
Capital International Investors1,916,947$747.4M-1,116,665
Northern Trust Corp1,708,560$666.2M-43,567
Fmr LLC1,632,520$636.5M-2,768,503
Invesco Ltd.1,529,637$596.4M+91,112
Nordea Investment Management AB1,429,943$553.7M-17,606
Barclays PLC1,319,216$514.3M+70,901

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

20 insiders reported holding 215,416,369 shares in total, about $101.34B at the last price.

HolderSharesAs of
Frist Thomas F IIIDirector, 10% owner 36,572,99936,557,141 held indirectly April 28, 2026
Frist William RDirector, 10% owner 36,570,88136,557,141 held indirectly April 28, 2026
Frist Thomas F Jr10% owner 36,557,14136,557,141 held indirectly February 6, 2026
Frisco Holding II10% owner 36,557,141 February 6, 2026
Elcan Patricia F10% owner 36,557,14136,557,141 held indirectly February 6, 2026
Hercules Holding II10% owner 32,282,889 February 6, 2026
Hazen Samuel NCEO, Director 80,86616,024 held indirectly February 10, 2026
Marks Mike AEVP and CFO 46,57646,576 held indirectly May 7, 2026
Wyatt Christopher F.SVP & Controller 44,379 February 11, 2026
Cuffe Michael S.EVP and Chief Clinical Officer 32,080 February 10, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HCA

What does HCA Healthcare, Inc. do?

HCA Healthcare operates general acute care hospitals, freestanding surgery centers, emergency rooms, and diagnostic clinics. It provides inpatient medical and surgical treatments, outpatient procedures, and emergency care services directly to patients across regional healthcare markets. Its shares trade on NYSE under the ticker HCA.

What is HCA Healthcare, Inc.'s net worth?

HCA Healthcare, Inc. has a market value (market cap) of $101.9B at the latest share price, and shareholders' equity of -$6.3B on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is HCA Healthcare, Inc. profitable?

Yes. Over the twelve months to March 31, 2026 it reported net income of $6.8B on revenue of $76.4B, a net margin of 8.9%.

How much revenue does HCA Healthcare, Inc. make?

Over the twelve months to March 31, 2026 HCA Healthcare, Inc. reported revenue of $76.4B. That is 6.7% more than a year earlier.

When did HCA Healthcare, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 28, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the new insider holdings from September 11, 2026.

When is HCA Healthcare, Inc.'s next earnings report?

HCA Healthcare, Inc.'s next report is expected around October 23, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Does HCA Healthcare, Inc. pay a dividend?

Yes. HCA Healthcare, Inc. declared dividends of $2.88 per share in fiscal 2025, a yield of 0.61% at the current price.

Similar companies

Compare HCA with

Compare HCA with any company

Follow HCA

Get an email when HCA Healthcare, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when HCA files with the SEC.

Where the numbers come from

Financial figures are the values HCA Healthcare, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.